Abstract
The Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, in Moscow, Russia, was established in 1953. For more than 25 years it was headed by late Professor GF Gause and, from 1986, it was directed by the late Professor Yurii V Dudnik. In the process of screening for new biologically active substances, a number of antibiotics were developed based on original strains isolated in the Institute, and these were produced on industrial scale for the pharmaceutical industry. These include antibacterial antibiotics gramicidin S, monomycin (paromomycin), colimycin (neomycin), albomycin, ristomycin, lincomycin, kanamycin, heliomycin and representatives of nearly all-important groups of antitumour antibiotics, e.g. olivomycin, bruneomycin (streptonigrine), rubomycin (daunorubicin), carminomycin and bleomycetin (bleomycin A-5).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
